Control group:Qiangxin Mixture simulation agent + conventional western medicine treatment
Sponsors
Shanghai Hospital of Traditional Chinese Medicine
Conditions
Heart Failure
Early Phase 1
A survey of clinical efficacy observation:combined with Qiangxin mixture for vulnerable phase of patients
Active, not recruitingChiCTR2000037007
Start: 2020-10-01Updated: 2020-09-28
A survey of clinical efficacy observation:combined with Qiangxin mixture for vulnerable phase of patients
Active, not recruitingITMCTR2000003980
Start: 2020-10-01Updated: 2023-02-20